EPCAM and neoplasm: The Muc1 gene is one of the markers included in a commercial test (AdnaTest BreastCancer®) which combines immunomagnetic tumor cell selection targeting EpCAM and MUC1 followed by multiplex RT-qPCR for the transcripts EpCAM, MUC1 and HER2.